IP Library Granted Patent US 11,559,688
Granted Patent B2
US 11,559,688 · App. 16/536,274 · Granted Jan 24, 2023

System and method for neuromodulation

Inventors: Stephen C. Masson (Raleigh, NC); Terrance Ransbury (Chapel Hill, NC); Richard S Stack (Chapel Hill, NC); William E Sanders (Chapel Hill, NC)
Assignee: NuXcel2, LLC
A61N1/36135A61N1/056A61N1/0551A61N1/36053A61N1/36114A61N1/36117A61N1/36139
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,559,688
App. No.
16/536,274
Granted
Jan 24, 2023
Kind
B2
Abstract

A method of treating a patient having a blood pressure comprises delivering neuromodulation therapy to sustain or increase the blood pressure. The neuromodulation therapy includes placing a sympathetic therapy electrode in a posterior portion of a blood vessel and stimulating at least one extravascular cardiac sympathetic nerve fiber using said electrode.

Claims (10)

1. A neuromodulation system for treating a patient, comprising:

a therapy device adapted for positioning within a blood vessel;

a parasympathetic therapy element and a sympathetic therapy element, the therapy device including a distal portion configured to be expandable to an expanded position within the blood vessel, wherein in the expanded position the parasympathetic therapy element and the sympathetic therapy element are positioned in a zone that extends circumferentially from 120 degrees to 240 degrees measured from a mid-anterior point around the circumference of the therapy device; and

a stimulator having a control means with (a) a parasympathetic control function configured to (a) energize the parasympathetic therapy element within the zone in accordance with parasympathetic therapeutic levels selected to capture an efferent parasympathetic nerve fiber that influences heart rate and (b) a sympathetic control function configured to energize the sympathetic therapy element within the zone in accordance with sympathetic therapeutic levels selected to capture an efferent cardiac sympathetic nerve fiber that influences blood pressure, the parasympathetic therapeutic levels and sympathetic therapeutic levels selected to decrease the patient's heart rate and elevate or maintain the blood pressure of the patient during simultaneous operation of the parasympathetic control function and the sympathetic control function.

2. The system of claim 1 , wherein the control means is configured to, during operation of the parasympathetic and sympathetic control functions, control the parasympathetic and sympathetic stimulation in response to sensed heart rate and/or blood pressure of the patient.

3. The system of claim 2 , wherein the control means independently controls the parasympathetic and sympathetic stimulation.

4. The system of claim 1 , wherein the therapy device is proportioned such that the distal portion in the expanded position has a diameter proportioned to bias the sympathetic and parasympathetic elements in contact with a surrounding wall of the blood vessel.

5. The system of claim 4 , wherein the distal portion is expandable or biased to position the parasympathetic element against a postero-lateral wall of a superior vena cava and to position the sympathetic element against a postero-medial segment of the superior vena cava.

6. The system of claim 1 wherein the therapy device is a catheter.

7. The system of claim 1 , wherein the sympathetic and parasympathetic elements are electrodes.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 28, 2021
From: INTERVENTIONAL AUTONOMICS CORPORATION
To: NUXCEL2, LLC
Reel/Frame 058487/0278 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2020
From: SANDERS, WILLIAM E; RANSBURY, TERRENCE; MASSON, STEPHEN C; STACK, RICHARD S
To: SYNECOR LLC
Reel/Frame 052795/0981 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 31, 2020
From: SYNECOR LLC
To: INTERVENTIONAL AUTONOMICS CORPORATION
Reel/Frame 052795/0986 →
Continuity (10)
Continuation 15237894 · Aug 16, 2016
Continuation 14516734 · Oct 17, 2014
Continuation 13547031 · Jul 11, 2012
Provisional Application 61506164 · Jul 11, 2011
Provisional Application 61551418 · Oct 25, 2011
Provisional Application 61584812 · Jan 9, 2012
Provisional Application 61601501 · Feb 21, 2012
Provisional Application 61613433 · Mar 20, 2012
Provisional Application 61639982 · Apr 29, 2012
Related Publication 20200206512A1 · Jul 2, 2020